Lukas Leow
Lukas Leow is a fund manager at Bellevue Asset Management, a Swiss investment firm that specializes in healthcare investments. He has been actively involved in discussions related to the pharmaceutical market, particularly regarding the performance and forecasts of companies like Novo Nordisk, in which he holds shares. Recently, he commented on the company's sales growth expectations for its obesity drug Wegovy.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Bulgaria:
Lukas Leow is a fund manager at Bellevue Asset Management in Switzerland.
6
Bulgaria:
Lukas Leow is a fund manager at Bellevue Asset Management and discussed the sales growth forecast for 2025.
6